Wealth Enhancement Advisory Services’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22,168
Closed -$396K 3697
2025
Q2
$396K Buy
22,168
+934
+4% +$16.5K ﹤0.01% 2399
2025
Q1
$374K Buy
21,234
+9,125
+75% +$183K ﹤0.01% 2264
2024
Q4
$294K Buy
12,109
+500
+4% +$14.3K ﹤0.01% 2396
2024
Q3
$431K Buy
11,609
+266
+2% +$9.92K ﹤0.01% 1922
2024
Q2
$540K Buy
11,343
+418
+4% +$18.3K ﹤0.01% 1603
2024
Q1
$418K Buy
10,925
+1,915
+21% +$62.3K ﹤0.01% 1698
2023
Q4
$281K Buy
9,010
+1,447
+19% +$52K ﹤0.01% 1857
2023
Q3
$304K Buy
+7,563
New +$354K ﹤0.01% 1733

Other funds holding STAA

Wealth Enhancement Advisory Services's STAA Position: Q3 2025 in Review

Wealth Enhancement Advisory Services sold out of STAAR Surgical (STAA) in Q3 2025, closing a stake of 22,168 shares — an estimated $396K sold.

Wealth Enhancement Advisory Services first reported a position in STAA in Q3 2023 and held it in 8 quarters. The position peaked at $540K in Q2 2024. 196 funds tracked by Wall St. Rank hold STAA as of Q3 2025.

  • Wealth Enhancement Advisory Services reported no remaining STAAR Surgical position as of Q3 2025 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 22,168 STAAR Surgical shares in Q3 2025, an estimated $396K.
  • Wealth Enhancement Advisory Services first reported a position in STAAR Surgical in Q3 2023 and held it in 8 quarters.
  • Wealth Enhancement Advisory Services's STAAR Surgical position peaked at $540K in Q2 2024.
  • 196 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2025.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2025, filed 29 Oct 2025.